These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32442677)

  • 21. Integrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects.
    Wang Y; Cao S; Yu K; Yang F; Yu X; Zhai Y; Wu C; Xu Y
    Int J Nanomedicine; 2019; 14():5849-5863. PubMed ID: 31440050
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful treatment with topical tacrolimus for oral psoriasis.
    Yamamoto T; Nishioka K
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1137-8. PubMed ID: 16987275
    [No Abstract]   [Full Text] [Related]  

  • 23. Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review.
    Dattola A; Silvestri M; Bennardo L; Del Duca E; Longo C; Bianchi L; Nisticò S
    Dermatol Ther; 2018 Nov; 31(6):e12728. PubMed ID: 30295379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generalized pustular psoriasis successfully treated with topical tacrolimus.
    Rodríguez García F; Fagundo González E; Cabrera-Paz R; Rodriguez Martín M; Sáez Rodríguez M; Martín-Neda F; García Bustinduy M; Noda Cabrera A; Sánchez González R
    Br J Dermatol; 2005 Mar; 152(3):587-8. PubMed ID: 15787845
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%.
    Rallis E; Nasiopoulou A; Kouskoukis C; Roussaki-Schulze A; Koumantaki E; Karpouzis A; Arvanitis A
    Drugs Exp Clin Res; 2005; 31(4):141-5. PubMed ID: 16223203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus ointment is effective for facial and intertriginous psoriasis.
    Lebwohl M; Freeman AK; Chapman MS; Feldman SR; Hartle JE; Henning A;
    J Am Acad Dermatol; 2004 Nov; 51(5):723-30. PubMed ID: 15523350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging trends in combination strategies with phototherapy in advanced psoriasis management.
    Sreya R; Nene S; Pathade V; Singh SB; Srivastava S
    Inflammopharmacology; 2023 Aug; 31(4):1761-1778. PubMed ID: 37326755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical vitamin D analogs available to treat psoriasis.
    Oquendo M; Abramovits W; Morrell P
    Skinmed; 2012; 10(6):356-60. PubMed ID: 23346664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus ointment 0.1% alone and in combination with medium-dose UVA1 in the treatment of palmar or plantar psoriasis.
    Rivard J; Janiga J; Lim HW
    J Drugs Dermatol; 2006 Jun; 5(6):505-10. PubMed ID: 16774101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
    Liao YH; Chiu HC; Tseng YS; Tsai TF
    Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.
    Biswasroy P; Pradhan D; Kar B; Ghosh G; Rath G
    AAPS PharmSciTech; 2021 May; 22(5):164. PubMed ID: 34041632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus ointment for the treatment of severe facial plaque psoriasis.
    Kroft EB; Erceg A; Maimets K; Vissers W; van der Valk PG; van de Kerkhof PC
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):249-51. PubMed ID: 15752305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical tacrolimus for the treatment of inflammatory skin diseases.
    Assmann T; Homey B; Ruzicka T
    Expert Opin Pharmacother; 2001 Jul; 2(7):1167-75. PubMed ID: 11583067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis.
    Viegas JSR; Praça FG; Caron AL; Suzuki I; Silvestrini AVP; Medina WSG; Del Ciampo JO; Kravicz M; Bentley MVLB
    Drug Deliv Transl Res; 2020 Jun; 10(3):646-660. PubMed ID: 32060883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clearing of psoriasis by a novel immunosuppressive macrolide.
    Rappersberger K; Meingassner JG; Fialla R; Födinger D; Sterniczky B; Rauch S; Putz E; Stütz A; Wolff K
    J Invest Dermatol; 1996 Apr; 106(4):701-10. PubMed ID: 8618008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential new indications of topical calcineurin inhibitors.
    Luger T; Paul C
    Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic ciclosporin and tacrolimus in dermatology.
    Madan V; Griffiths CE
    Dermatol Ther; 2007; 20(4):239-50. PubMed ID: 17970889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients.
    Brune A; Miller DW; Lin P; Cotrim-Russi D; Paller AS
    Pediatr Dermatol; 2007; 24(1):76-80. PubMed ID: 17300658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment.
    Carroll CL; Clarke J; Camacho F; Balkrishnan R; Feldman SR
    Arch Dermatol; 2005 Jan; 141(1):43-6. PubMed ID: 15655140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclodextrin-Coordinated Liposome-in-Gel for Transcutaneous Quercetin Delivery for Psoriasis Treatment.
    Zhang Y; Gong S; Liu L; Shen H; Liu E; Pan L; Gao N; Chen R; Huang Y
    ACS Appl Mater Interfaces; 2023 Aug; 15(34):40228-40240. PubMed ID: 37584330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.